Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly

Immunity

Volumn 37, Issue 5, 2012, Pages 771-783

  Kollmann, Tobias R ^a   Levy, Ofer ^b   Montgomery, Ruth R ^c   Goriely, Stanislas ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR;

AGED; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION RISK; INNATE IMMUNITY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK FACTOR;

AGE FACTORS; AGED; CYTOKINES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; TOLL-LIKE RECEPTORS;

EID: 84869228450     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.10.014     Document Type: Review

References (213)

1. Afrazi A., Sodhi C.P., Richardson W., Neal M., Good M., Siggers R., Hackam D.J. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr. Res. 2011, 69:183-188.
2. Agrawal A., Agrawal S., Cao J.N., Su H., Osann K., Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 2007, 178:6912-6922.
3. Agrawal A., Agrawal S., Gupta S. Dendritic cells in human aging. Exp. Gerontol. 2007, 42:421-426.
4. Aksoy E., Albarani V., Nguyen M., Laes J.F., Ruelle J.L., De Wit D., Willems F., Goldman M., Goriely S. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 2007, 109:2887-2893.
5. Azizia M., Lloyd J., Allen M., Klein N., Peebles D. Immune status in very preterm neonates. Pediatrics 2012, 129:e967-e974.
6. Balasubramani A., Mukasa R., Hatton R.D., Weaver C.T. Regulation of the Ifng locus in the context of T-lineage specification and plasticity. Immunol. Rev. 2010, 238:216-232.
7. Barker D.J. The origins of the developmental origins theory. J. Intern. Med. 2007, 261:412-417.
8. Baxter D. Impaired functioning of immune defenses to infection in premature and term infants and their implications for vaccination. Hum. Vaccin. 2010, 6:494-505.
9. Belderbos M.E., van Bleek G.M., Levy O., Blanken M.O., Houben M.L., Schuijff L., Kimpen J.L.L., Bont L. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin. Immunol. 2009, 133:228-237.
10. Belderbos M.E., Houben M.L., van Bleek G.M., Schuijff L., van Uden N.O., Bloemen-Carlier E.M., Kimpen J.L., Eijkemans M.J., Rovers M., Bont L.J. Breastfeeding modulates neonatal innate immune responses: A prospective birth cohort study. Pediatr. Allergy Immunol. 2012, 23:65-74.
11. Biagi E., Nylund L., Candela M., Ostan R., Bucci L., Pini E., Nikkïla J., Monti D., Satokari R., Franceschi C., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 2010, 5:e10667.
12. Black A., Bhaumik S., Kirkman R.L., Weaver C.T., Randolph D.A. Developmental regulation of Th17-cell capacity in human neonates. Eur. J. Immunol. 2012, 42:311-319.
13. Blimkie D., Fortuno E.S., Yan H., Cho P., Ho K., Turvey S.E., Marchant A., Goriely S., Kollmann T.R. Variables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation. J. Immunol. Methods 2011, 366:89-99.
14. Bonafe M., Storci G., Franceschi C. Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays 2012, 34:40-49.
15. Bouhuys A.L., Flentge F., Oldehinkel A.J., van den Berg M.D. Potential psychosocial mechanisms linking depression to immune function in elderly subjects. Psychiatry Res. 2004, 127:237-245.
16. Bourée P. Immunity and immunization in elderly. Pathol. Biol. (Paris) 2003, 51:581-585.
17. Brereton C.F., Sutton C.E., Ross P.J., Iwakura Y., Pizza M., Rappuoli R., Lavelle E.C., Mills K.H. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. J. Immunol. 2011, 186:5896-5906.
18. Bruunsgaard H., Ladelund S., Pedersen A.N., Schroll M., Jørgensen T., Pedersen B.K. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin. Exp. Immunol. 2003, 132:24-31.
19. Bruunsgaard H., Pedersen A.N., Schroll M., Skinhoj P., Pedersen B.K. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin. Exp. Immunol. 1999, 118:235-241.
20. Buonaguro L., Pulendran B. Immunogenomics and systems biology of vaccines. Immunol. Rev. 2011, 239:197-208.
21. Burl S., Adetifa U.J., Cox M., Touray E., Ota M.O., Marchant A., Whittle H., McShane H., Rowland-Jones S.L., Flanagan K.L. Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J. Immunol. 2010, 185:2620-2628.
22. Burl S., Townend J., Njie-Jobe J., Cox M., Adetifa U.J., Touray E., Philbin V.J., Mancuso C., Kampmann B., Whittle H., et al. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS ONE 2011, 6:e18185.
23. Canaday D.H., Amponsah N.A., Jones L., Tisch D.J., Hornick T.R., Ramachandra L. Influenza-induced production of interferon-alpha is defective in geriatric individuals. J. Clin. Immunol. 2010, 30:373-383.
24. Carty M., Bowie A.G. Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem. Pharmacol. 2011, 81:825-837.
25. Casals F., Sikora M., Laayouni H., Montanucci L., Muntasell A., Lazarus R., Calafell F., Awadalla P., Netea M.G., Bertranpetit J. Genetic adaptation of the antibacterial human innate immunity network. BMC Evol. Biol. 2011, 11:202.
26. Casanova J.L., Abel L. Primary immunodeficiencies: a field in its infancy. Science 2007, 317:617-619.
27. Chang B.A., Huang Q., Quan J., Chau V., Ladd M., Kwan E., McFadden D.E., Lacaze-Masmonteil T., Miller S.P., Lavoie P.M. Early inflammation in the absence of overt infection in preterm neonates exposed to intensive care. Cytokine 2011, 56:621-626.
28. Charrel-Dennis M., Latz E., Halmen K.A., Trieu-Cuot P., Fitzgerald K.A., Kasper D.L., Golenbock D.T. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 2008, 4:543-554.
29. Chen K., Huang J., Gong W., Iribarren P., Dunlop N.M., Wang J.M. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 2007, 7:1271-1285.
30. Cheng A.C., Currie B.J. Melioidosis: Epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 2005, 18:383-416.
31. Cheung G.Y., Otto M. Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children. Curr. Opin. Infect. Dis. 2010, 23:208-216.
32. Ciaramella A., Spalletta G., Bizzoni F., Salani F., Caltagirone C., Bossù P. Effect of age on surface molecules and cytokine expression in human dendritic cells. Cell. Immunol. 2011, 269:82-89.
33. Corbett N.P., Blimkie D., Ho K.C., Cai B., Sutherland D.P., Kallos A., Crabtree J., Rein-Weston A., Lavoie P.M., Turvey S.E., et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 2010, 5:e15041.
34. Cuervo A.M., Bergamini E., Brunk U.T., Dröge W., Ffrench M., Terman A. Autophagy and aging: the importance of maintaining " clean" cells. Autophagy 2005, 1:131-140.
35. Currie A.J., Curtis S., Strunk T., Riley K., Liyanage K., Prescott S., Doherty D., Simmer K., Richmond P., Burgner D. Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus. Infect. Immun. 2011, 79:1588-1596.
36. D'Angio C.T. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability. Paediatr. Drugs 2007, 9:17-32.
37. Danis B., George T.C., Goriely S., Dutta B., Renneson J., Gatto L., Fitzgerald-Bocarsly P., Marchant A., Goldman M., Willems F., De Wit D. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur. J. Immunol. 2008, 38:507-517.
38. Dasari P., Zola H., Nicholson I.C. Expression of Toll-like receptors by neonatal leukocytes. Pediatr. Allergy Immunol. 2011, 22:221-228.
39. De Paepe M.E., Hanley L.C., Lacourse Z., Pasquariello T., Mao Q. Pulmonary dendritic cells in lungs of preterm infants: neglected participants in bronchopulmonary dysplasia?. Pediatr. Dev. Pathol. 2011, 14:20-27.
40. Della Bella S., Bierti L., Presicce P., Arienti R., Valenti M., Saresella M., Vergani C., Villa M.L. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol. 2007, 122:220-228.
41. Di Bona D., Cippitelli M., Fionda C., Cammà C., Licata A., Santoni A., Craxì A. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J. Hepatol. 2006, 45:271-279.
42. Dietert R.R. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer. Reprod. Toxicol. 2011, 31:319-326.
43. Donald P.R., Marais B.J., Barry C.E. Age and the epidemiology and pathogenesis of tuberculosis. Lancet 2010, 375:1852-1854.
44. Drygiannakis I., Ernst P.B., Lowe D., Glomski I.J. Immunological alterations mediated by adenosine during host-microbial interactions. Immunol. Res. 2011, 50:69-77.
45. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., Flavell R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
46. Esposito S., Serra D., Gualtieri L., Cesati L., Principi N. Vaccines and preterm neonates: why, when, and with what. Early Hum. Dev. 2009, 85(10, Suppl):S43-S45.
47. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., Longo D.L. The origins of age-related proinflammatory state. Blood 2005, 105:2294-2299.
48. Ferrucci L., Guralnik J.M., Pahor M., Corti M.C., Havlik R.J. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997, 277:728-734.
49. Figueiredo C.A., Alcântara-Neves N.M., Veiga R., Amorim L.D., Dattoli V., Mendonça L.R., Junqueira S., Genser B., Santos M., de Carvalho L.C., et al. Spontaneous cytokine production in children according to biological characteristics and environmental exposures. Environ. Health Perspect. 2009, 117:845-849.
50. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
51. Fleer A., Krediet T.G. Innate immunity: Toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn. Neonatology 2007, 92:145-157.
52. Fleming D.M., Elliot A.J. The impact of influenza on the health and health care utilisation of elderly people. Vaccine 2005, 23(Suppl 1):S1-S9.
53. Forsey R.J., Thompson J.M., Ernerudh J., Hurst T.L., Strindhall J., Johansson B., Nilsson B.O., Wikby A. Plasma cytokine profiles in elderly humans. Mech. Ageing Dev. 2003, 124:487-493.
54. Fortin C.F., McDonald P.P., Lesur O., Fülöp T. Aging and neutrophils: there is still much to do. Rejuvenation Res. 2008, 11:873-882.
55. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
56. Fulop T., Kotb R., Fortin C.F., Pawelec G., de Angelis F., Larbi A. Potential role of immunosenescence in cancer development. Ann. N Y Acad. Sci. 2010, 1197:158-165.
57. Gabrielsson S., Söderlund A., Nilsson C., Lilja G., Nordlund M., Troye-Blomberg M. Influence of atopic heredity on IL-4-, IL-12- and IFN-gamma-producing cells in in vitro activated cord blood mononuclear cells. Clin. Exp. Immunol. 2001, 126:390-396.
58. Gaffen S.L., Hernández-Santos N., Peterson A.C. IL-17 signaling in host defense against Candida albicans. Immunol. Res. 2011, 50:181-187.
59. Gan Y.H. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy?. J. Infect. Dis. 2005, 192:1845-1850.
60. Goldenberg R.L., McClure E.M., Saleem S., Reddy U.M. Infection-related stillbirths. Lancet 2010, 375:1482-1490.
61. Goldin L.R., Landgren O., Kristinsson S.Y., Björkholm M., Paltiel O. Infection in infancy and subsequent risk of developing lymphoma in children and young adults. Blood 2011, 117:1670-1672.
62. Goldstein D.R. Role of aging on innate responses to viral infections. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:242-246.
63. Goriely S., Van Lint C., Dadkhah R., Libin M., De Wit D., Demonté D., Willems F., Goldman M. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J. Exp. Med. 2004, 199:1011-1016.
64. Goriely S., Goldman M. Interleukin-12 family members and the balance between rejection and tolerance. Curr. Opin. Organ Transplant. 2008, 13:4-9.
65. Goriely S., Neurath M.F., Goldman M. How microorganisms tip the balance between interleukin-12 family members. Natl. Rev. 2008, 8:81-86.
66. Gourlay D.M. The good and the bad of the innate immune response in necrotizing enterocolitis. J. Surg. Res. 2012, 175:51-53.
67. Gow N.A., van de Veerdonk F.L., Brown A.J., Netea M.G. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat. Rev. Microbiol. 2011, 10:112-122.
68. Graham J.E., Christian L.M., Kiecolt-Glaser J.K. Stress, age, and immune function: Toward a lifespan approach. J. Behav. Med. 2006, 29:389-400.
69. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. J. Pathol. 2007, 211:144-156.
70. Hedayat M., Netea M.G., Rezaei N. Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect. Dis. 2011, 11:702-712.
71. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Thaiss C.A., Kau A.L., Eisenbarth S.C., Jurczak M.J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
72. Hipkiss A.R. Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+-controlled protein glycation. Adv. Clin. Chem. 2010, 50:123-150.
73. Huang C.C., Liu K., Pope R.M., Du P., Lin S., Rajamannan N.M., Huang Q.Q., Jafari N., Burke G.L., Post W., et al. Activated TLR signaling in atherosclerosis among women with lower Framingham risk score: the multi-ethnic study of atherosclerosis. PLoS ONE 2011, 6:e21067.
74. Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y.H., Wang H., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249.
75. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 2007, 21:374-383.
76. Jing Y., Shaheen E., Drake R.R., Chen N., Gravenstein S., Deng Y. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum. Immunol. 2009, 70:777-784.
77. Kasturi S.P., Skountzou I., Albrecht R.A., Koutsonanos D., Hua T., Nakaya H.I., Ravindran R., Stewart S., Alam M., Kwissa M., et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 2011, 470:543-547.
78. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
79. Kenzel S., Henneke P. The innate immune system and its relevance to neonatal sepsis. Curr. Opin. Infect. Dis. 2006, 19:264-270.
80. Kittan N.A., Bergua A., Haupt S., Donhauser N., Schuster P., Korn K., Harrer T., Schmidt B. Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virus-associated acute retinal necrosis. J. Immunol. 2007, 179:4219-4230.
81. Kollmann T.R., Crabtree J., Rein-Weston A., Blimkie D., Thommai F., Wang X.Y., Lavoie P.M., Furlong J., Fortuno E.S., Hajjar A.M., et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 2009, 183:7150-7160.
82. Kong K.-F., Delroux K., Wang X., Qian F., Arjona A., Malawista S.E., Fikrig E., Montgomery R.R. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 2008, 82:7613-7623.
83. Krabbe K.S., Pedersen M., Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol. 2004, 39:687-699.
84. Kramer B.W., Kallapur S., Newnham J., Jobe A.H. Prenatal inflammation and lung development. Semin. Fetal Neonatal Med. 2009, 14:2-7.
85. Ku C.L., von Bernuth H., Picard C., Zhang S.Y., Chang H.H., Yang K., Chrabieh M., Issekutz A.C., Cunningham C.K., Gallin J., et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 2007, 204:2407-2422.
86. Lavoie P.M., Huang Q., Jolette E., Whalen M., Nuyt A.M., Audibert F., Speert D.P., Lacaze-Masmonteil T., Soudeyns H., Kollmann T.R. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. J. Infect. Dis. 2010, 202:1754-1763.
87. Lawn J.E., Cousens S., Zupan J. 4 million neonatal deaths: when? Where? Why?. Lancet 2005, 365:891-900. Lancet Neonatal Survival Steering Team.
88. Leavy O. (micro)Tolerance in the gut. Natl. Rev. 2010, 10:810.
89. LeBouder E., Rey-Nores J.E., Raby A.C., Affolter M., Vidal K., Thornton C.A., Labéta M.O. Modulation of neonatal microbial recognition: TLR-mediated innate immune responses are specifically and differentially modulated by human milk. J. Immunol. 2006, 176:3742-3752.
90. Lemke G., Rothlin C.V. Immunobiology of the TAM receptors. Natl. Rev. 2008, 8:327-336.
91. Leng J., Goldstein D.R. Impact of aging on viral infections. Microbes Infect. 2010, 12:1120-1124.
92. Levy O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Natl. Rev. 2007, 7:379-390.
93. Levy O., Coughlin M., Cronstein B.N., Roy R.M., Desai A., Wessels M.R. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 2006, 177:1956-1966.
94. Levy O., Zarember K.A., Roy R.M., Cywes C., Godowski P.J., Wessels M.R. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 2004, 173:4627-4634.
95. Lewis D.B., Gern J.E., Hill H.R., Friedlander S.L., La Pine T.R., Lemanske R.F., Stiehm E.R. Newborn immunology: relevance to the clinician. Curr. Probl. Pediatr. Adolesc. Health Care 2006, 36:189-204.
96. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Müller-Hermelink H.K., Steinmann G.G. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 1984, 28:47-55.
97. Lin P.W., Stoll B.J. Necrotising enterocolitis. Lancet 2006, 368:1271-1283.
98. Lisciandro J.G., Prescott S.L., Nadal-Sims M.G., Devitt C.J., Pomat W., Siba P.M., Tulic M.C., Holt P.G., Strickland D., van den Biggelaar A.H. Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants. PLoS ONE 2012, 7:e36793.
99. Lisciandro J.G., van den Biggelaar A.H. Neonatal immune function and inflammatory illnesses in later life: lessons to be learnt from the developing world?. Clin. Exp. Allergy 2010, 40:1719-1731.
100. Lotz M., Gütle D., Walther S., Ménard S., Bogdan C., Hornef M.W. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J. Exp. Med. 2006, 203:973-984.
101. Malaguarnera L., Cristaldi E., Malaguarnera M. The role of immunity in elderly cancer. Crit. Rev. Oncol. Hematol. 2010, 74:40-60.
102. Malamitsi-Puchner A., Protonotariou E., Boutsikou T., Makrakis E., Sarandakou A., Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum. Dev. 2005, 81:387-392.
103. Mancuso G., Gambuzza M., Midiri A., Biondo C., Papasergi S., Akira S., Teti G., Beninati C. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 2009, 10:587-594.
104. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Natl. Rev. 2011, 11:519-531.
105. Martin C.R., Walker W.A. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin. Fetal Neonatal Med. 2006, 11:369-377.
106. Martino D.J., Tulic M.K., Gordon L., Hodder M., Richman T., Metcalfe J., Prescott S.L., Saffery R. Evidence for age-related and individual-specific changes in DNA methylation profile of mononuclear cells during early immune development in humans. Epigenetics 2011, 6:1085-1094.
107. McElhaney J.E., Effros R.B. Immunosenescence: What does it mean to health outcomes in older adults?. Curr. Opin. Immunol. 2009, 21:418-424.
108. McElhaney J.E., Zhou X., Talbot H.K., Soethout E., Bleackley R.C., Granville D.J., Pawelec G. The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012, 30:2060-2067.
109. Melchjorsen J. Sensing herpes: More than toll. Rev. Med. Virol. 2012, 22:106-121.
110. Melvan J.N., Bagby G.J., Welsh D.A., Nelson S., Zhang P. Neonatal sepsis and neutrophil insufficiencies. Int. Rev. Immunol. 2010, 29:315-348.
111. Mira J.P., Max A., Burgel P.R. The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy. Crit. Care 2008, 12(Suppl 6):S5.
112. Mold J.E., Venkatasubrahmanyam S., Burt T.D., Michaëlsson J., Rivera J.M., Galkina S.A., Weinberg K., Stoddart C.A., McCune J.M. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 2010, 330:1695-1699.
113. Mook P., Patel B., Gillespie I.A. Risk factors for mortality in non-pregnancy-related listeriosis. Epidemiol. Infect. 2012, 140:706-715.
114. Moore S.E., Collinson A.C., Fulford A.J., Jalil F., Siegrist C.A., Goldblatt D., Hanson L.A., Prentice A.M. Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop. Med. Int. Health 2006, 11:1529-1541.
115. Moore S.E., Collinson A.C., Tamba N'Gom P., Aspinall R., Prentice A.M. Early immunological development and mortality from infectious disease in later life. Proc. Nutr. Soc. 2006, 65:311-318.
116. Mortellaro A., Ricciardi-Castagnoli P. From vaccine practice to vaccine science: The contribution of human immunology to the prevention of infectious disease. Immunol. Cell Biol. 2011, 89:332-339.
117. Mueller N.H., Gilden D.H., Cohrs R.J., Mahalingam R., Nagel M.A. Varicella zoster virus infection: Clinical features, molecular pathogenesis of disease, and latency. Neurol. Clin. 2008, 26:675-697. viii.
118. Myśliwska J., Bryl E., Foerster J., Myśliwski A. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech. Ageing Dev. 1998, 100:313-328.
119. Nanthakumar N., Meng D., Goldstein A.M., Zhu W., Lu L., Uauy R., Llanos A., Claud E.C., Walker W.A. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: An immature innate immune response. PLoS ONE 2011, 6:e17776.
120. Nassi N., Ponziani V., Becatti M., Galvan P., Donzelli G. Anti-oxidant enzymes and related elements in term and preterm newborns. Pediatr. Int. 2009, 51:183-187.
121. Nathe K.E., Parad R., Van Marter L.J., Lund C.A., Suter E.E., Hernandez-diaz S., Boush E.B., Ikonomu E., Gallington L., Morey J.A., et al. Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatr. Res. 2009, 66:191-196.
122. Negishi H., Yanai H., Nakajima A., Koshiba R., Atarashi K., Matsuda A., Matsuki K., Miki S., Doi T., Aderem A., et al. Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat. Immunol. 2012, 13:659-666.
123. Netea M.G., Quintin J., van der Meer J.W. Trained immunity: A memory for innate host defense. Cell Host Microbe 2011, 9:355-361.
124. Netea M.G., van de Veerdonk F.L., van Deuren M., van der Meer J.W. Defects of pattern recognition: primary immunodeficiencies of the innate immune system. Curr. Opin. Pharmacol. 2011, 11:412-422.
125. Netea M.G., van der Meer J.W. Immunodeficiency and genetic defects of pattern-recognition receptors. N. Engl. J. Med. 2011, 364:60-70.
126. Netea M.G., Wijmenga C., O'Neill L.A. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 2012, 13:535-542.
127. Nguyen M., Leuridan E., Zhang T., De Wit D., Willems F., Van Damme P., Goldman M., Goriely S. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE 2010, 5:e10407.
128. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. 2003, 348:1322-1332.
129. Nilsson C., Larsson A.K., Höglind A., Gabrielsson S., Troye Blomberg M., Lilja G. Low numbers of interleukin-12-producing cord blood mononuclear cells and immunoglobulin E sensitization in early childhood. Clin. Exp. Allergy 2004, 34:373-380.
130. Nyugen J., Agrawal S., Gollapudi S., Gupta S. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J. Clin. Immunol. 2010, 30:806-813.
131. Ongradi J., Kovesdi V. Factors that may impact on immunosenescence: An appraisal. Immun. Ageing 2010, 7:7.
132. Ota M.O., Vekemans J., Schlegel-Haueter S.E., Fielding K., Sanneh M., Kidd M., Newport M.J., Aaby P., Whittle H., Lambert P.H., et al. Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J. Immunol. 2002, 168:919-925.
133. Ottenhoff T.H., Verreck F.A., Hoeve M.A., van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis (Edinb.) 2005, 85:53-64.
134. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., Lord J.M., Shaw A.C. Human innate immunosenescence: Causes and consequences for immunity in old age. Trends Immunol. 2009, 30:325-333.
135. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., Chen S., Towle V., Belshe R.B., Fikrig E., et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J. Immunol. 2010, 184:2518-2527.
136. Pattenden S.G., Klose R., Karaskov E., Bremner R. Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent. EMBO J. 2002, 21:1978-1986.
137. Paul-Clark M.J., McMaster S.K., Sorrentino R., Sriskandan S., Bailey L.K., Moreno L., Ryffel B., Quesniaux V.F., Mitchell J.A. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am. J. Respir. Crit. Care Med. 2009, 179:299-306.
138. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., Ferrucci L., Harris T., Pahor M. Inflammatory markers and depressed mood in older persons: Results from the Health, Aging and Body Composition study. Biol. Psychiatry 2003, 54:566-572.
139. Petrikin J.E., Gaedigk R., Leeder J.S., Truog W.E. Selective Toll-like receptor expression in human fetal lung. Pediatr. Res. 2010, 68:335-338.
140. Philbin V.J., Dowling D.J., Gallington L.C., Cortes G., Tan Z., Suter E.E., Chi K.W., Shuckett A., Stoler-Barak L., Tomai M., et al. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. J. Allergy Clin. Immunol. 2012, 130:195-204. e9.
141. Plackett T.P., Boehmer E.D., Faunce D.E., Kovacs E.J. Aging and innate immune cells. J. Leukoc. Biol. 2004, 76:291-299.
142. Posfay-Barbe K.M., Wald E.R. Listeriosis. Semin. Fetal Neonatal Med. 2009, 14:228-233.
143. Power Coombs M.R., Belderbos M.E., Gallington L.C., Bont L., Levy O. Adenosine modulates Toll-like receptor function: Basic mechanisms and translational opportunities. Expert Rev. Anti Infect. Ther. 2011, 9:261-269.
144. Pulendran B., Ahmed R. Translating innate immunity into immunological memory: Implications for vaccine development. Cell 2006, 124:849-863.
145. Qian F., Wang X., Zhang L., Chen S., Piecychna M., Allore H., Bockenstedt L., Malawista S., Bucala R., Shaw A.C., et al. Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell 2012, 11:104-110.
146. Qian F., Wang X., Zhang L., Lin A., Zhao H., Fikrig E., Montgomery R.R. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J. Infect. Dis. 2011, 203:1415-1424.
147. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., Black J.C., Hoffmann A., Carey M., Smale S.T. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138:114-128.
148. Randhawa A.K., Shey M.S., Keyser A., Peixoto B., Wells R.D., de Kock M., Lerumo L., Hughes J., Hussey G., Hawkridge A., et al. Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants. PLoS Pathog. 2011, 7:e1002174. South African Tuberculosis Vaccine Initiative Team.
149. Ravaglia G., Forti P., Maioli F., Chiappelli M., Montesi F., Tumini E., Mariani E., Licastro F., Patterson C. Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging. Neurobiol. Aging 2007, 28:1810-1820.
150. Rayamajhi M., Humann J., Kearney S., Hill K.K., Lenz L.L. Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections. Virulence 2010, 1:418-422.
151. Reece P., Thanendran A., Crawford L., Tulic M.K., Thabane L., Prescott S.L., Sehmi R., Denburg J.A. Maternal allergy modulates cord blood hematopoietic progenitor Toll-like receptor expression and function. J. Allergy Clin. Immunol. 2011, 127:447-453.
152. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am. J. Epidemiol. 2004, 160:492-502.
153. Reikie B.A., Adams R.C., Ruck C.E., Ho K., Leligdowicz A., Pillay S., Naidoo S., Fortuno E.S., de Beer C., Preiser W., et al. Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life. PLoS ONE 2012, 7:e44763.
154. Renz H., Brandtzaeg P., Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Natl. Rev. 2012, 12:9-23.
155. Reuben D.B., Cheh A.I., Harris T.B., Ferrucci L., Rowe J.W., Tracy R.P., Seeman T.E. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J. Am. Geriatr. Soc. 2002, 50:638-644.
156. Ridda I., Macintyre C.R., Lindley R., Gao Z., Sullivan J.S., Yuan F.F., McIntyre P.B. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009, 27:1628-1636.
157. Romagne F. Current and future drugs targeting one class of innate immunity receptors: The Toll-like receptors. Drug Discov. Today 2007, 12:80-87.
158. Rubartelli A., Gattorno M., Netea M.G., Dinarello C.A. Interplay between redox status and inflammasome activation. Trends Immunol. 2011, 32:559-566.
159. Sampath V., Le M., Lane L., Patel A.L., Cohen J.D., Simpson P.M., Garland J.S., Hines R.N. The NFKB1 (g.-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J. Surg. Res. 2011, 169:e51-e57.
160. Schiffrin E.J., Morley J.E., Donnet-Hughes A., Guigoz Y. The inflammatory status of the elderly: The intestinal contribution. Mutat. Res. 2010, 690:50-56.
161. Scholtes V.P., Versteeg D., de Vries J.P., Hoefer I.E., Schoneveld A.H., Stella P.R., Doevendans P.A., van Keulen K.J., de Kleijn D.P., Moll F.L., Pasterkamp G. Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis. Clin. Sci. 2011, 121:205-214.
162. Shanks N., Windle R.J., Perks P.A., Harbuz M.S., Jessop D.S., Ingram C.D., Lightman S.L. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc. Natl. Acad. Sci. USA 2000, 97:5645-5650.
163. Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr. Opin. Immunol. 2010, 22:507-513.
164. Shaw A.C., Panda A., Joshi S.R., Qian F., Allore H.G., Montgomery R.R. Dysregulation of human Toll-like receptor function in aging. Ageing Res. Rev. 2011, 10:346-353.
165. Shurin G.V., Yurkovetsky Z.R., Chatta G.S., Tourkova I.L., Shurin M.R., Lokshin A.E. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine 2007, 39:123-129.
166. Simpson A.J., Newton P.N., Chierakul W., Chaowagul W., White N.J. Diabetes mellitus, insulin, and melioidosis in Thailand. Clin. Infect. Dis. 2003, 36:e71-e72.
167. Smeekens S.P., Plantinga T.S., van de Veerdonk F.L., Heinhuis B., Hoischen A., Joosten L.A., Arkwright P.D., Gennery A., Kullberg B.J., Veltman J.A., et al. STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis. PLoS ONE 2011, 6:e29248.
168. Stout-Delgado H.W., Yang X., Walker W.E., Tesar B.M., Goldstein D.R. Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J. Immunol. 2008, 181:6747-6756.
169. Strunk T., Currie A., Richmond P., Simmer K., Burgner D. Innate immunity in human newborn infants: prematurity means more than immaturity. J. Matern. Fetal Neonatal Med. 2011, 24:25-31.
170. Strunk T., Doherty D., Jacques A., Simmer K., Richmond P., Kohan R., Charles A., Burgner D. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 2012, 129:e134-e141.
171. Strunk T., Doherty D., Richmond P., Simmer K., Charles A., Levy O., Liyanage K., Smith T., Currie A., Burgner D. Reduced levels of antimicrobial proteins and peptides in human cord blood plasma. Arch. Dis. Child. Fetal Neonatal Ed. 2009, 94:F230-F231.
172. Strunk T., Power Coombs M.R., Currie A.J., Richmond P., Golenbock D.T., Stoler-Barak L., Gallington L.C., Otto M., Burgner D., Levy O. TLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremia. PLoS ONE 2010, 5:e10111.
173. Strunk T., Prosser A., Levy O., Philbin V., Simmer K., Doherty D., Charles A., Richmond P., Burgner D., Currie A. Responsiveness of human monocytes to the commensal bacterium Staphylococcus epidermidis develops late in gestation. Pediatr. Res. 2012, 72:10-18.
174. Strunk T., Richmond P., Simmer K., Currie A., Levy O., Burgner D. Neonatal immune responses to coagulase-negative staphylococci. Curr. Opin. Infect. Dis. 2007, 20:370-375.
175. Strunk T., Simmer K., Burgner D. Prematurity and mortality in childhood and early adulthood. JAMA 2012, 307:32. author reply 32-33.
176. Tal M.C., Iwasaki A. Mitoxosome: A mitochondrial platform for cross-talk between cellular stress and antiviral signaling. Immunol. Rev. 2011, 243:215-234.
177. Tal M.C., Sasai M., Lee H.K., Yordy B., Shadel G.S., Iwasaki A. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc. Natl. Acad. Sci. USA 2009, 106:2770-2775.
178. Taylor A., Hale J., Wiltschut J., Lehmann H., Dunstan J.A., Prescott S.L. Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy. Clin. Exp. Allergy 2006, 36:1218-1226.
179. Taylor D.N., Treanor J.J., Strout C., Johnson C., Fitzgerald T., Kavita U., Ozer K., Tussey L., Shaw A. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine 2011, 29:4897-4902.
180. Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 2010, 12:503-535.
181. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
182. Travis J. Nobel Prize in physiology or medicine. Immunology prize overshadowed by untimely death of awardee. Science 2011, 334:31.
183. Trzonkowski P., Myśliwska J., Godlewska B., Szmit E., Łukaszuk K., Wieckiewicz J., Brydak L., Machała M., Landowski J., Myśliwski A. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav. Immun. 2004, 18:135-148.
184. Trzonkowski P., Myśliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., Machała M., Myśliwski A. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-An impact of immunosenescence. Vaccine 2003, 21:3826-3836.
185. Tsuda K., Iwasaki S., Horiguchi H., Mori M., Nishimaki S., Seki K., Taguri M., Yokota S., Ishiwada N. Immune response to Haemophilus influenzae type b conjugate vaccine in preterm infants. Pediatr. Int. 2011, 54:64-67.
186. Tulic M.K., Hodder M., Forsberg A., McCarthy S., Richman T., D'Vaz N., van den Biggelaar A.H., Thornton C.A., Prescott S.L. Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny. J. Allergy Clin. Immunol. 2011, 127:470-478.
187. Uciechowski P., Imhoff H., Lange C., Meyer C.G., Browne E.N., Kirsten D.K., Schröder A.K., Schaaf B., Al-Lahham A., Reinert R.R., et al. Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression. J. Leukoc. Biol. 2011, 90:377-388.
188. Vallejo A.N., Hamel D.L., Mueller R.G., Ives D.G., Michel J.J., Boudreau R.M., Newman A.B. NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PLoS ONE 2011, 6:e26558.
189. van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., Arts P., Rosentul D.C., Carmichael A.J., Smits-van der Graaf C.A., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 2011, 365:54-61.
190. van den Biggelaar A.H., Huizinga T.W., de Craen A.J., Gussekloo J., Heijmans B.T., Frölich M., Westendorp R.G. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp. Gerontol. 2004, 39:1407-1414.
191. van den Biggelaar A.H., Prescott S.L., Roponen M., Nadal-Sims M.A., Devitt C.J., Phuanukoonnon S., Pomat W., Tulic M.K., Lehmann D., Siba P.M., et al. Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J. Allergy Clin. Immunol. 2009, 124:544-550.
192. van Duin D., Allore H.G., Mohanty S., Ginter S., Newman F.K., Belshe R.B., Medzhitov R., Shaw A.C. Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J. Infect. Dis. 2007, 195:1590-1597.
193. van Duin D., Mohanty S., Thomas V., Ginter S., Montgomery R.R., Fikrig E., Allore H.G., Medzhitov R., Shaw A.C. Age-associated defect in human TLR-1/2 function. J. Immunol. 2007, 178:970-975.
194. Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 17:179-188.
195. Vanden Eijnden S., Goriely S., De Wit D., Goldman M., Willems F. Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur. J. Immunol. 2006, 36:21-26.
196. Vellai T. Autophagy genes and ageing. Cell Death Differ. 2009, 16:94-102.
197. Venkatesh M.P., Placencia F., Weisman L.E. Coagulase-negative staphylococcal infections in the neonate and child: An update. Semin. Pediatr. Infect. Dis. 2006, 17:120-127.
198. Vento S., Tanko M.N. The bacterium that could cause cancer. Lancet Oncol. 2009, 10:528.
199. Volpe J.J. Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants. J. Pediatr. 2008, 153:160-163.
200. Vuillermin P.J., Ponsonby A.L., Saffery R., Tang M.L., Ellis J.A., Sly P., Holt P. Microbial exposure, interferon gamma gene demethylation in naïve T-cells, and the risk of allergic disease. Allergy 2009, 64:348-353.
201. Weyrich P., Staiger H., Stančáková A., Machicao F., Machann J., Schick F., Stefan N., Kuusisto J., Laakso M., Schäfer S., et al. The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: Results from the TULIP and METSIM Studies. PLoS ONE 2010, 5:e13980.
202. White N.J. Melioidosis. Lancet 2003, 361:1715-1722.
203. Wiersinga W.J., van der Poll T., White N.J., Day N.P., Peacock S.J. Melioidosis: Insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 2006, 4:272-282.
204. Wijsman C.A., Maier A.B., de Craen A.J., van den Biggelaar A.H., Westendorp R.G. An unopposed proinflammatory response is beneficial for survival in the oldest old. Results of the Leiden 85-plus Study. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:393-399.
205. Wikby A., Nilsson B.O., Forsey R., Thompson J., Strindhall J., Löfgren S., Ernerudh J., Pawelec G., Ferguson F., Johansson B. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Ageing Dev. 2006, 127:695-704.
206. Wilson C.B., Kollmann T.R. Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr. Workshop Ser. Pediatr. Program. 2008, 61:183-195.
207. Wynn J.L., Scumpia P.O., Winfield R.D., Delano M.J., Kelly-Scumpia K., Barker T., Ungaro R., Levy O., Moldawer L.L. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008, 112:1750-1758.
208. Xiao N., Eidenschenk C., Krebs P., Brandl K., Blasius A.L., Xia Y., Khovananth K., Smart N.G., Beutler B. The Tpl2 mutation Sluggish impairs type I IFN production and increases susceptibility to group B streptococcal disease. J. Immunol. 2009, 183:7975-7983.
209. Yanagisawa S., Koarai A., Sugiura H., Ichikawa T., Kanda M., Tanaka R., Akamatsu K., Hirano T., Matsunaga K., Minakata Y., Ichinose M. Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects. Respir. Res. 2009, 10:50.
210. Yoshikawa T.T. Important infections in elderly persons. West. J. Med. 1981, 135:441-445.
211. Zhang J.P., Yang Y., Levy O., Chen C. Human neonatal peripheral blood leukocytes demonstrate pathogen-specific coordinate expression of TLR2, TLR4/MD2, and MyD88 during bacterial infection in vivo. Pediatr. Res. 2010, 68:479-483.
212. Zhang S.Y., Boisson-Dupuis S., Chapgier A., Yang K., Bustamante J., Puel A., Picard C., Abel L., Jouanguy E., Casanova J.L. Inborn errors of interferon (IFN)-mediated immunity in humans: Insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol. Rev. 2008, 226:29-40.
213. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 2010, 11:136-140.